Rikoon Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,521
Closed -$482K 211
2019
Q4
$482K Hold
2,521
0.17% 127
2019
Q3
$424K Hold
2,521
0.16% 131
2019
Q2
$422K Hold
2,521
0.16% 132
2019
Q1
$369K Buy
2,521
+611
+32% +$88.6K 0.14% 141
2018
Q4
$255K Buy
1,910
+177
+10% +$29K 0.11% 163
2018
Q3
$330K Buy
1,733
+67
+4% +$12.3K 0.12% 163
2018
Q2
$278K Hold
1,666
0.11% 173
2018
Q1
$270K Buy
+1,666
New +$279K 0.11% 165
2017
Q4
Sell
-1,802
Closed -$369K 170
2017
Q3
$369K Hold
1,802
0.16% 125
2017
Q2
$438K Buy
1,802
+155
+9% +$36.4K 0.19% 111
2017
Q1
$402K Hold
1,647
0.18% 116
2016
Q4
$405K Buy
+1,647
New +$341K 0.18% 115

Other funds holding AGN

Rikoon Group's AGN Position: Q1 2020 in Review

Rikoon Group sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 2,521 shares — an estimated $482K sold.

Rikoon Group first reported a position in AGN in Q4 2016 and held it in 12 quarters. The position peaked at $482K in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Rikoon Group reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Rikoon Group sold 2,521 Allergan plc shares in Q1 2020, an estimated $482K.
  • Rikoon Group first reported a position in Allergan plc in Q4 2016 and held it in 12 quarters.
  • Rikoon Group's Allergan plc position peaked at $482K in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Rikoon Group's 13F filing for Q1 2020, filed 30 Apr 2020.